Geoffrey J Yoon, MD
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
- Since medical school
- 19 years
- Johns Hopkins University School of Medicine, 2007
Offices
6 locations · Southern California Permanente Medical Group · 11,250 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital - Orange County - Anahe. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Yoon’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A105364 · Current
Licensed to practise in California · since 2008 · expires 2028-08-31 · Johns Hopkins University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Advanced Heart Failure and Transplant
- American Board of Internal Medicine - Cardiology
- American Board of Internal Medicine - Cardiovascular Disease
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital - Orange County - AnaheimAnaheim, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.464, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital - Orange County - Anaheim
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.464 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.06) · 243 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.44 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 30 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.9 · 384 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 5,690 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.03 to 0.5) · 1,022 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,065 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.59 (1.09 to 6.09) · 235 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.51 to 3.87) · 220 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.14 (0 to 17.63) · 87 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (0.75 to 9.22) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.27) · 59 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.36 (0 to 1.38) · 815 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.7 · 448 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.646 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.55 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.678 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.406 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 262 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 989 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -53.7 · 43 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20 · 1,221 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.2 · 459 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 275 cases | None | Jul 2023 – Jun 2025 |
What patients said (1,903 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 80% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$1,278
Medicare paid this office $1,278 for 27 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
27 Original Medicare patients in 2024. Average age 71 · Women 44% · Health risk score 2.03. At or below the middle of the specialty; the typical advanced heart failure and transplant cardiology clinician is at 2.53.
Conditions among them: High blood pressure 74% · Diabetes 41%.
The office billed $8,427, Medicare allowed $2,418 and paid $1,278; for 34 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 27 | 34 | 71 | 2.03 | $8,427 | $1,278 |
| 2023 | 20 | 33 | 72 | 3.20 | $10,431 | $2,088 |
| 2022 | 20 | 28 | 72 | 0.99 | $9,351 | $1,738 |
| 2021 | 34 | 50 | 72 | 1.47 | $11,210 | $2,641 |
| 2019 | 1,837 | 3,848 | 77 | 1.44 | $1,139,630 | $280,018 |
| 2018 | 1,615 | 3,413 | 77 | 1.37 | $938,797 | $242,438 |
| 2017 | 1,614 | 3,589 | 77 | 1.41 | $1,083,848 | $289,712 |
| 2016 | 1,496 | 3,055 | 77 | 1.39 | $831,215 | $219,670 |
| 2015 | 1,141 | 2,487 | 76 | 1.21 | $762,804 | $202,858 |
| 2014 | 302 | 601 | 76 | 1.13 | $233,439 | $64,465 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2021: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 14 | $96 | $6 |
2019: 27 services
| Return visit (30+ min) | 312 | $51,982 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 174 | $38,915 | $209 |
| Long return visit (40+ min) | 164 | $37,619 | $130 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 40 | $19,843 | $496 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 55 | $19,825 | $94 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 59 | $13,166 | $223 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 770 | $12,642 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 157 | $11,149 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $10,838 | $178 |
| New patient visit (45+ min) | 70 | $9,998 | $143 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 31 | $5,348 | $88 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 21 | $5,310 | $253 |
| Injection, regadenoson, 0.1 mg | 25 | $4,597 | None |
| Critical care, first 30-74 minutes | 11 | $3,976 | $199 |
| New patient visit (60+ min) | 22 | $3,916 | $178 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 68 | $3,889 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 389 | $3,537 | $7 |
| Programming of dual lead pacemaker system | 29 | $2,689 | $60 |
| External ekg recording for more than 48 hours up to 21 days | 103 | $2,650 | $25 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 103 | $2,371 | $23 |
| Electrocardiogram (ecg) 2-day continuous | 56 | $1,447 | $25 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 56 | $1,369 | $24 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,194 | $100 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report | 18 | $841 | $47 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 17 | $707 | $25 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 12 | $483 | $40 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $256 | $11 |
2018: 22 services
| Return visit (30+ min) | 273 | $50,441 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 151 | $32,872 | $208 |
| Long return visit (40+ min) | 109 | $26,710 | $127 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 44 | $22,605 | $514 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $18,256 | $94 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 726 | $11,682 | $16 |
| New patient visit (45+ min) | 72 | $10,516 | $146 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 44 | $9,780 | $222 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $9,278 | $182 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 114 | $8,031 | $65 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 31 | $5,851 | $94 |
| Injection, regadenoson, 0.1 mg | 32 | $5,532 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 68 | $4,259 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 321 | $2,778 | $7 |
| Programming of dual lead pacemaker system | 28 | $2,262 | $51 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 13 | $2,178 | $87 |
| External ekg recording for more than 48 hours up to 21 days | 56 | $1,533 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 56 | $1,358 | $23 |
| Electrocardiogram (ecg) 2-day continuous | 34 | $907 | $26 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 34 | $831 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 12 | $426 | $28 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $143 | $11 |
2017: 27 services
| Long return visit (40+ min) | 154 | $39,716 | $126 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 156 | $36,805 | $224 |
| Return visit (30+ min) | 214 | $35,664 | $91 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 62 | $31,219 | $504 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $19,960 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $15,067 | $179 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 57 | $14,989 | $263 |
| New patient visit (60+ min) | 69 | $12,423 | $180 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 62 | $11,776 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 173 | $11,145 | $56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 701 | $10,962 | $15 |
| Critical care, first 30-74 minutes | 19 | $7,699 | $192 |
| Injection, regadenoson, 0.1 mg | 39 | $6,515 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 89 | $5,725 | $63 |
| New patient visit (45+ min) | 24 | $3,454 | $144 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $3,086 | $257 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 323 | $2,947 | $7 |
| Hospital discharge day management, more than 30 minutes | 23 | $2,455 | $98 |
| Programming of dual lead pacemaker system | 23 | $1,982 | $52 |
| Electrocardiogram (ecg) 2-day continuous | 52 | $1,377 | $26 |
| Short return visit (20+ min) | 22 | $1,324 | $60 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 51 | $1,224 | $24 |
| External ekg recording for more than 48 hours up to 21 days | 40 | $1,101 | $27 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,036 | $65 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 40 | $965 | $24 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $273 | $11 |
| Injection, aminophyllin, up to 250 mg | 13 | $10 | None |
2016: 25 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 144 | $34,850 | $223 |
| Return visit (30+ min) | 148 | $31,335 | $93 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 58 | $28,946 | $499 |
| Long return visit (40+ min) | 69 | $15,453 | $133 |
| New patient visit (60+ min) | 67 | $12,408 | $185 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 59 | $11,259 | $95 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 41 | $10,952 | $267 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 649 | $9,384 | $14 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $8,055 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $7,982 | $177 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 106 | $6,985 | $66 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 119 | $6,700 | $55 |
| Injection, regadenoson, 0.1 mg | 41 | $6,641 | None |
| Short return visit (20+ min) | 58 | $4,178 | $60 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $3,485 | $268 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 321 | $2,755 | $7 |
| New patient visit (45+ min) | 16 | $1,982 | $124 |
| Electrocardiogram (ecg) 2-day continuous | 53 | $1,426 | $26 |
| Programming of dual lead pacemaker system | 15 | $1,384 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,350 | $64 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 53 | $1,280 | $23 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,167 | $97 |
| External ekg recording for more than 48 hours up to 21 days | 31 | $843 | $26 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 15 | $759 | $51 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 30 | $720 | $23 |
2015: 23 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 117 | $27,642 | $230 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 54 | $27,208 | $504 |
| Return visit (30+ min) | 110 | $23,156 | $100 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 54 | $14,272 | $132 |
| Long return visit (40+ min) | 61 | $13,443 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $11,772 | $95 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 649 | $10,305 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 139 | $8,143 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $7,462 | $178 |
| Injection, regadenoson, 0.1 mg | 42 | $6,782 | None |
| New patient visit (60+ min) | 37 | $6,749 | $182 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 23 | $6,457 | $281 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 86 | $5,867 | $67 |
| New patient visit (45+ min) | 40 | $5,581 | $140 |
| Short return visit (20+ min) | 46 | $4,524 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,264 | $67 |
| Electrocardiogram (ecg) 2-day continuous | 46 | $1,295 | $28 |
| Programming of dual lead pacemaker system | 14 | $1,279 | $56 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 46 | $1,129 | $24 |
| External ekg recording for more than 48 hours up to 21 days | 23 | $615 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 23 | $526 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $38 | $3 |
| Injection, aminophyllin, up to 250 mg | 13 | $23 | None |
2014: 15 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 55 | $12,679 | $231 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 15 | $7,353 | $490 |
| Return visit (30+ min) | 29 | $5,404 | $100 |
| New patient visit (45+ min) | 33 | $4,879 | $148 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 15 | $3,955 | $132 |
| New patient visit (60+ min) | 20 | $3,629 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $3,420 | $92 |
| Long return visit (40+ min) | 17 | $3,067 | $133 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 40 | $2,239 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,158 | $180 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 117 | $1,855 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 20 | $1,321 | $66 |
| Short return visit (20+ min) | 11 | $681 | $62 |
| Electrocardiogram (ecg) 2-day continuous | 11 | $308 | $28 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 11 | $267 | $24 |
Medicaid work
$80,744 in 2024
Medicaid paid $80,744 for 806 billed services this clinician did in 2024, up to 63 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 455 | $75,966 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 351 | $4,777 |
| 2024 | 806 | 2 | 63 | $80,744 |
| 2023 | 105 | 2 | 30 | $1,074 |
| 2019 | 206 | 2 | 58 | $1,533 |
| 2018 | 237 | 2 | 58 | $2,553 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 48 | $1,052 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 57 | $22 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 161 | $783 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 45 | $750 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 81 | $1,731 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 156 | $822 |
Drugs they prescribed that Part D paid
$857,803
Pharmacies billed $857,803 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,464 generic and 609 brand-name prescriptions · $857,803 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vyndaqel | 12 | $292,310 | $24,359 |
| Eliquis | 195 | $284,229 | $1,458 |
| Entresto | 58 | $83,279 | $1,436 |
| Jardiance | 105 | $51,267 | $488 |
| Repatha Sureclick | 78 | $48,607 | $623 |
See all 38 drugs
| Vyndaqel | 12 | $292,310 | $24,359 |
| Eliquis | 195 | $284,229 | $1,458 |
| Entresto | 58 | $83,279 | $1,436 |
| Jardiance | 105 | $51,267 | $488 |
| Repatha Sureclick | 78 | $48,607 | $623 |
| Pradaxa | 119 | $35,023 | $294 |
| Xarelto | 14 | $9,626 | $688 |
| Atorvastatin | 316 | $3,992 | $13 |
| Dabigatran Etexilate | 20 | $3,487 | $174 |
| Bisoprolol | 145 | $3,162 | $22 |
| Diltiazem 24hr Er (Cd) | 73 | $2,685 | $37 |
| Losartan | 152 | $2,116 | $14 |
| Amiodarone | 63 | $1,933 | $31 |
| Cartia Xt | 45 | $1,930 | $43 |
| Isosorbide Mononitrate Er | 131 | $1,827 | $14 |
| Metoprolol | 160 | $1,598 | $10 |
| Amlodipine Besylate | 119 | $1,582 | $13 |
| Metoprolol | 98 | $1,463 | $15 |
| Carvedilol | 120 | $1,429 | $12 |
| Potassium Chloride | 43 | $1,319 | $31 |
| Clopidogrel | 69 | $1,308 | $19 |
| Lisinopril | 94 | $1,290 | $14 |
| Spironolactone | 123 | $1,276 | $10 |
| Furosemide | 95 | $1,127 | $12 |
| Rosuvastatin | 88 | $1,094 | $12 |
| Ranolazine Er | 15 | $1,012 | $67 |
| Diltiazem | 33 | $980 | $30 |
| Ezetimibe | 87 | $926 | $11 |
| Hydralazine | 46 | $906 | $20 |
| Flecainide Acetate | 25 | $856 | $34 |
| Pantoprazole | 61 | $780 | $13 |
| Isosorbide Dinitrate | 16 | $565 | $35 |
| Torsemide | 17 | $447 | $26 |
| Digoxin | 25 | $355 | $14 |
| Nitroglycerin | 20 | $352 | $18 |
| Hydrochlorothiazide | 23 | $268 | $12 |
| Atenolol | 21 | $250 | $12 |
| Losartan-Hydrochlorothiazide | 11 | $128 | $12 |
Year by year
| 2024 | 3,073 | 516 | None | 20% | $857,803 |
| 2023 | 2,385 | 416 | 0% (0) | None | $414,345 |
| 2022 | 1,721 | 316 | 0% (0) | None | $274,088 |
| 2021 | 1,087 | 219 | None | 20% | $184,766 |
| 2020 | 1,606 | 386 | 0% (0) | 19% | $279,245 |
| 2019 | 3,184 | 397 | 0% (0) | 20% | $517,673 |
| 2018 | 2,606 | 313 | None | 16% | $316,990 |
| 2017 | 1,971 | 268 | 0% (0) | 22% | $201,632 |
| 2016 | 1,550 | 208 | 0% (0) | 23% | $133,820 |
| 2015 | 878 | 150 | 0% (0) | 25% | $57,923 |
| 2014 | 270 | 73 | 0% (0) | 26% | $18,213 |
| 2013 | 106 | 24 | 0% (0) | 21% | $9,082 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 33 drugs
| Eliquis | 138 | $180,044 | $1,305 |
| Entresto | 37 | $49,561 | $1,339 |
| Pradaxa | 115 | $34,612 | $301 |
| Jardiance | 52 | $28,214 | $543 |
| Repatha Sureclick | 23 | $13,930 | $606 |
| Xarelto | 14 | $13,549 | $968 |
| Diltiazem 24hr Er (Cd) | 106 | $3,065 | $29 |
| Bisoprolol | 118 | $2,841 | $24 |
| Metoprolol | 97 | $2,766 | $29 |
| Atorvastatin | 178 | $2,683 | $15 |
| Rosuvastatin | 141 | $1,747 | $12 |
| Amiodarone | 52 | $1,653 | $32 |
| Lisinopril | 112 | $1,487 | $13 |
| Amlodipine Besylate | 112 | $1,447 | $13 |
| Losartan | 109 | $1,447 | $13 |
| Metoprolol | 131 | $1,302 | $10 |
| Ranolazine Er | 14 | $1,189 | $85 |
| Isosorbide Mononitrate Er | 85 | $1,095 | $13 |
| Carvedilol | 84 | $1,043 | $12 |
| Spironolactone | 103 | $1,029 | $10 |
| Potassium Chloride | 33 | $1,023 | $31 |
| Clopidogrel | 51 | $1,022 | $20 |
| Furosemide | 78 | $978 | $13 |
| Pantoprazole | 57 | $814 | $14 |
| Digoxin | 36 | $753 | $21 |
| Flecainide Acetate | 21 | $726 | $35 |
| Isosorbide Dinitrate | 12 | $638 | $53 |
| Hydralazine | 32 | $630 | $20 |
| Ezetimibe | 39 | $382 | $10 |
| Atenolol | 23 | $332 | $14 |
| Torsemide | 16 | $302 | $19 |
| Diltiazem | 14 | $291 | $21 |
| Hydrochlorothiazide | 20 | $230 | $12 |
2022: 27 drugs
| Eliquis | 102 | $151,001 | $1,480 |
| Entresto | 28 | $35,215 | $1,258 |
| Pradaxa | 69 | $32,133 | $466 |
| Jardiance | 12 | $7,498 | $625 |
| Diltiazem 24hr Er (Cd) | 89 | $2,522 | $28 |
| Bisoprolol | 67 | $2,253 | $34 |
| Amiodarone | 53 | $2,158 | $41 |
| Rosuvastatin | 165 | $2,156 | $13 |
| Metoprolol | 94 | $2,121 | $23 |
| Atorvastatin | 81 | $1,266 | $16 |
| Lisinopril | 93 | $1,199 | $13 |
| Isosorbide Dinitrate | 19 | $1,176 | $62 |
| Losartan | 86 | $1,127 | $13 |
| Furosemide | 63 | $992 | $16 |
| Metoprolol | 98 | $948 | $10 |
| Carvedilol | 74 | $926 | $13 |
| Amlodipine Besylate | 60 | $840 | $14 |
| Spironolactone | 84 | $838 | $10 |
| Digoxin | 34 | $815 | $24 |
| Isosorbide Mononitrate Er | 54 | $674 | $12 |
| Clopidogrel | 31 | $644 | $21 |
| Atenolol | 31 | $502 | $16 |
| Hydralazine | 19 | $393 | $21 |
| Diltiazem | 16 | $374 | $23 |
| Hydrochlorothiazide | 25 | $300 | $12 |
| Ezetimibe | 16 | $285 | $18 |
| Pantoprazole | 19 | $269 | $14 |
2021: 23 drugs
| Eliquis | 68 | $102,959 | $1,514 |
| Pradaxa | 60 | $41,677 | $695 |
| Cartia Xt | 35 | $1,835 | $52 |
| Metoprolol | 57 | $1,470 | $26 |
| Rosuvastatin | 103 | $1,382 | $13 |
| Diltiazem 24hr Er (Cd) | 28 | $1,070 | $38 |
| Bisoprolol | 32 | $1,008 | $31 |
| Lisinopril | 66 | $858 | $13 |
| Losartan | 57 | $754 | $13 |
| Metoprolol | 80 | $745 | $9 |
| Atorvastatin | 45 | $660 | $15 |
| Furosemide | 45 | $640 | $14 |
| Spironolactone | 58 | $587 | $10 |
| Carvedilol | 46 | $580 | $13 |
| Amlodipine Besylate | 40 | $567 | $14 |
| Ezetimibe | 13 | $537 | $41 |
| Amiodarone | 15 | $513 | $34 |
| Isosorbide Mononitrate Er | 38 | $457 | $12 |
| Diltiazem | 15 | $444 | $30 |
| Hydralazine | 16 | $413 | $26 |
| Atenolol | 22 | $366 | $17 |
| Digoxin | 12 | $364 | $30 |
| Pantoprazole | 13 | $216 | $17 |
2020: 31 drugs
| Eliquis | 132 | $160,501 | $1,216 |
| Xarelto | 28 | $27,343 | $977 |
| Pradaxa | 42 | $25,638 | $610 |
| Entresto | 19 | $21,103 | $1,111 |
| Metoprolol | 133 | $4,271 | $32 |
| Diltiazem 24hr Er (Cd) | 55 | $4,010 | $73 |
| Rosuvastatin | 99 | $3,113 | $31 |
| Atorvastatin | 123 | $2,206 | $18 |
| Losartan | 132 | $1,892 | $14 |
| Clopidogrel | 57 | $1,160 | $20 |
| Digoxin | 23 | $965 | $42 |
| Hydralazine | 41 | $957 | $23 |
| Cartia Xt | 18 | $929 | $52 |
| Amlodipine Besylate | 98 | $877 | $9 |
| Spironolactone | 65 | $726 | $11 |
| Isosorbide Mononitrate Er | 28 | $683 | $24 |
| Flecainide Acetate | 14 | $669 | $48 |
| Nifedipine Er | 11 | $669 | $61 |
| Furosemide | 71 | $647 | $9 |
| Carvedilol | 49 | $583 | $12 |
| Lisinopril | 55 | $466 | $8 |
| Bisoprolol | 12 | $449 | $37 |
| Ezetimibe | 11 | $432 | $39 |
| Metoprolol | 44 | $406 | $9 |
| Pantoprazole | 16 | $354 | $22 |
| Torsemide | 14 | $341 | $24 |
| Amiodarone | 15 | $331 | $22 |
| Atenolol | 20 | $215 | $11 |
| Nitroglycerin | 11 | $192 | $17 |
| Hydrochlorothiazide | 14 | $147 | $10 |
| Benazepril | 12 | $144 | $12 |
2019: 42 drugs
| Eliquis | 294 | $318,826 | $1,084 |
| Xarelto | 51 | $49,542 | $971 |
| Entresto | 56 | $45,415 | $811 |
| Metoprolol | 319 | $11,553 | $36 |
| Rosuvastatin | 118 | $7,934 | $67 |
| Diltiazem 24hr Er (Cd) | 94 | $7,276 | $77 |
| Pradaxa | 15 | $6,981 | $465 |
| Atorvastatin | 270 | $5,907 | $22 |
| Losartan | 187 | $3,253 | $17 |
| Clopidogrel | 130 | $2,789 | $21 |
| Isosorbide Dinitrate | 18 | $2,689 | $149 |
| Clonidine | 14 | $2,367 | $169 |
| Amlodipine Besylate | 180 | $2,173 | $12 |
| Flecainide Acetate | 24 | $2,016 | $84 |
| Cartia Xt | 41 | $1,979 | $48 |
| Spironolactone | 168 | $1,809 | $11 |
| Hydralazine | 73 | $1,781 | $24 |
| Digoxin | 60 | $1,716 | $29 |
| Labetalol | 15 | $1,660 | $111 |
| Furosemide | 202 | $1,563 | $8 |
| Valsartan | 26 | $1,561 | $60 |
| Torsemide | 52 | $1,479 | $28 |
| Isosorbide Mononitrate Er | 36 | $1,417 | $39 |
| Pantoprazole | 64 | $1,351 | $21 |
| Bisoprolol | 19 | $1,197 | $63 |
| Amiodarone | 34 | $1,158 | $34 |
| Carvedilol | 84 | $1,088 | $13 |
| Ezetimibe | 25 | $1,080 | $43 |
| Potassium Chloride | 18 | $1,001 | $56 |
| Nifedipine Er | 21 | $819 | $39 |
| Diltiazem 24hr Er | 11 | $774 | $70 |
| Digox | 22 | $641 | $29 |
| Pravastatin | 19 | $633 | $33 |
| Nitroglycerin | 33 | $628 | $19 |
| Lisinopril | 82 | $608 | $7 |
| Digitek | 13 | $605 | $47 |
| Enalapril Maleate | 25 | $486 | $19 |
| Benazepril | 37 | $441 | $12 |
| Clonidine | 21 | $382 | $18 |
| Metoprolol | 32 | $228 | $7 |
| Hydrochlorothiazide | 23 | $187 | $8 |
| Atenolol | 24 | $170 | $7 |
2018: 38 drugs
| Eliquis | 190 | $193,644 | $1,019 |
| Xarelto | 32 | $22,893 | $715 |
| Entresto | 20 | $14,699 | $735 |
| Metoprolol | 232 | $9,655 | $42 |
| Rosuvastatin | 92 | $5,550 | $60 |
| Atorvastatin | 232 | $5,272 | $23 |
| Diltiazem 24hr Er (Cd) | 62 | $5,047 | $81 |
| Isosorbide Dinitrate | 20 | $3,200 | $160 |
| Cartia Xt | 63 | $2,677 | $42 |
| Flecainide Acetate | 18 | $2,238 | $124 |
| Labetalol | 18 | $2,075 | $115 |
| Digoxin | 65 | $1,995 | $31 |
| Losartan | 128 | $1,925 | $15 |
| Clopidogrel | 79 | $1,814 | $23 |
| Hydralazine | 68 | $1,603 | $24 |
| Valsartan | 40 | $1,544 | $39 |
| Spironolactone | 145 | $1,527 | $11 |
| Digox | 35 | $1,501 | $43 |
| Potassium Chloride | 36 | $1,415 | $39 |
| Torsemide | 59 | $1,370 | $23 |
| Amlodipine Besylate | 124 | $1,305 | $11 |
| Enalapril Maleate | 36 | $1,120 | $31 |
| Furosemide | 181 | $1,116 | $6 |
| Amiodarone | 42 | $1,101 | $26 |
| Carvedilol | 85 | $1,020 | $12 |
| Isosorbide Mononitrate Er | 28 | $975 | $35 |
| Ezetimibe | 13 | $959 | $74 |
| Nifedipine Er | 22 | $955 | $43 |
| Pantoprazole | 42 | $795 | $19 |
| Bisoprolol | 19 | $737 | $39 |
| Diltiazem 24hr Er | 15 | $620 | $41 |
| Lisinopril | 72 | $555 | $8 |
| Nitroglycerin | 25 | $482 | $19 |
| Benazepril | 26 | $373 | $14 |
| Pravastatin | 11 | $292 | $27 |
| Clonidine | 30 | $269 | $9 |
| Hydrochlorothiazide | 26 | $259 | $10 |
| Metoprolol | 19 | $248 | $13 |
2017: 33 drugs
| Eliquis | 143 | $117,135 | $819 |
| Xarelto | 20 | $14,155 | $708 |
| Metoprolol | 195 | $7,743 | $40 |
| Atorvastatin | 216 | $4,519 | $21 |
| Diltiazem 24hr Er | 49 | $4,225 | $86 |
| Rosuvastatin | 40 | $3,696 | $92 |
| Labetalol | 29 | $3,139 | $108 |
| Isosorbide Dinitrate | 18 | $3,111 | $173 |
| Digoxin | 45 | $2,006 | $45 |
| Clopidogrel | 79 | $1,732 | $22 |
| Digox | 28 | $1,700 | $61 |
| Cartia Xt | 39 | $1,492 | $38 |
| Valsartan | 27 | $1,485 | $55 |
| Hydralazine | 64 | $1,378 | $22 |
| Losartan | 95 | $1,273 | $13 |
| Enalapril Maleate | 34 | $1,198 | $35 |
| Nitroglycerin | 47 | $1,056 | $22 |
| Spironolactone | 107 | $918 | $9 |
| Amlodipine Besylate | 82 | $908 | $11 |
| Torsemide | 39 | $807 | $21 |
| Nifedipine Er | 17 | $799 | $47 |
| Furosemide | 126 | $695 | $6 |
| Carvedilol | 62 | $650 | $10 |
| Pantoprazole | 23 | $489 | $21 |
| Isosorbide Mononitrate Er | 15 | $402 | $27 |
| Lisinopril | 37 | $350 | $9 |
| Clonidine | 22 | $236 | $11 |
| Hydrochlorothiazide | 30 | $229 | $8 |
| Amiodarone | 18 | $209 | $12 |
| Warfarin | 11 | $89 | $8 |
| Benazepril | 15 | $74 | $5 |
| Atenolol | 14 | $56 | $4 |
| Metoprolol | 21 | $54 | $3 |
2016: 30 drugs
| Eliquis | 98 | $63,344 | $646 |
| Xarelto | 22 | $13,960 | $635 |
| Metoprolol | 204 | $7,338 | $36 |
| Atorvastatin | 173 | $4,196 | $24 |
| Diltiazem 24hr Er | 36 | $3,230 | $90 |
| Clopidogrel | 74 | $1,939 | $26 |
| Hydralazine | 37 | $1,586 | $43 |
| Labetalol | 19 | $1,390 | $73 |
| Digoxin | 37 | $1,267 | $34 |
| Rosuvastatin | 11 | $1,235 | $112 |
| Isosorbide Dinitrate | 12 | $1,197 | $100 |
| Losartan | 75 | $1,094 | $15 |
| Spironolactone | 65 | $853 | $13 |
| Digox | 18 | $845 | $47 |
| Torsemide | 32 | $830 | $26 |
| Valsartan | 18 | $800 | $44 |
| Amlodipine Besylate | 72 | $675 | $9 |
| Potassium Chloride | 11 | $654 | $59 |
| Flecainide Acetate | 17 | $631 | $37 |
| Enalapril Maleate | 24 | $582 | $24 |
| Cartia Xt | 12 | $553 | $46 |
| Isosorbide Mononitrate Er | 26 | $484 | $19 |
| Furosemide | 98 | $468 | $5 |
| Nitrostat | 19 | $445 | $23 |
| Lisinopril | 40 | $368 | $9 |
| Carvedilol | 28 | $308 | $11 |
| Omeprazole | 13 | $306 | $24 |
| Amiodarone | 22 | $301 | $14 |
| Hydrochlorothiazide | 24 | $156 | $7 |
| Metoprolol | 20 | $104 | $5 |
2015: 23 drugs
| Xarelto | 39 | $18,862 | $484 |
| Eliquis | 25 | $13,865 | $555 |
| Metoprolol | 115 | $5,466 | $48 |
| Crestor | 11 | $3,010 | $274 |
| Atorvastatin | 85 | $2,174 | $26 |
| Clopidogrel | 38 | $1,007 | $26 |
| Losartan | 41 | $890 | $22 |
| Amlodipine Besylate | 49 | $489 | $10 |
| Isosorbide Mononitrate Er | 20 | $453 | $23 |
| Diltiazem 24hr Er | 17 | $423 | $25 |
| Nitrostat | 27 | $415 | $15 |
| Cartia Xt | 11 | $415 | $38 |
| Pantoprazole | 17 | $374 | $22 |
| Amiodarone | 27 | $358 | $13 |
| Spironolactone | 43 | $356 | $8 |
| Hydralazine | 14 | $313 | $22 |
| Furosemide | 57 | $281 | $5 |
| Omeprazole | 18 | $280 | $16 |
| Torsemide | 12 | $252 | $21 |
| Lisinopril | 25 | $218 | $9 |
| Carvedilol | 15 | $196 | $13 |
| Metoprolol | 26 | $152 | $6 |
| Hydrochlorothiazide | 14 | $59 | $4 |
2014: 7 drugs
| Xarelto | 13 | $4,813 | $370 |
| Crestor | 13 | $4,526 | $348 |
| Metoprolol | 17 | $813 | $48 |
| Atorvastatin | 23 | $649 | $28 |
| Amlodipine Besylate | 11 | $176 | $16 |
| Spironolactone | 12 | $130 | $11 |
| Furosemide | 24 | $109 | $5 |
2013: 1 drug
| Atorvastatin | 13 | $488 | $38 |
Money from drug and device companies
$21 in 2022
| 2022 | 1 | 1 | None | $21 |
| 2020 | 1 | 1 | $1,750 | $1,750 |
| 2019 | 2 | 3 | $1,750 | $1,909 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lantheus Medical Imaging | Definity | $21 | 1 payment
|
See the published payment
| Lantheus Medical Imaging | Meals · 2022-09-28 | Definity | $21 |
See earlier years (2020, 2019)
2020: $1,750
| Terumo Medical | None | $1,750 | 1 payment
|
2019: $1,909
| Terumo Medical | None | $1,750 | 2 payments
|
| Abbott Laboratories | Cardiomems Hf System | $159 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| CVRx, Inc. · Barostim Neo System · 2019 | Their institution | $7,841 |
Professional record
- NPI
- 1023298353
- Licence
- CA A105364California A105364: Current · expires 2028-08-31
- Trained
- Johns Hopkins University School of Medicine, 2007 · 19 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RA0001X (207RA0001X); Internal medicine (207R00000X); Cardiology (207RC0000X)
- Mailing address
- 393 E Walnut St, Fl 3, Pasadena, CA, 91188
- NPI first listed
- 2007-11-03
- NPI last updated
- 2021-11-29
- NPI record certified
- 2020-03-25
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.